Co-Head of M&A-Americas
Morgan Stanley, Investment Banking Division
RUSSELL L. CARSON
Co-Founder and General Partner
Welsh, Carson, Anderson & Stowe
Since 1978 Russell Carson has been a General Partner of Welsh, Carson, Anderson & Stowe (WCAS), one of the Country’s largest private investment firms, which he co-founded. Over the past 27 years, WCAS has raised fourteen institutionally funded limited partnerships with total capital in excess of $16 billion and has invested in more than 250 companies. The firm has evolved into the leading specialist in the buyout of privately owned companies in the information services and healthcare industries. Unlike many buyout firms, WCAS emphasizes the growth of acquired businesses and ultimately seeks its financial returns through access to the public stock market. Mr. Carson has focused on WCAS’s healthcare investment activities and is currently a director of four portfolio companies.
From 1967 to 1978 he was employed by Citicorp Venture Capital subsidiary of Citicorp and served as its Chairman and CEO from 1974 to 1978.
Active in community affairs, Mr. Carson is a Trustee of Dartmouth College, Chairman of The Rockefeller University Board of Trustees, Co-Chairman of the Board of Overseers of Columbia Business School, a Trustee of the Metropolitan Museum of Art, a Director of the Partnership for New York City, a Co-Chairman of the New York City Investment Fund, a Director of the World Trade Center Memorial Foundation and Chairman of the Endowment for Inner-City Education.
Mr. Carson attended public high school in Toledo, Ohio, prior to receiving a BA degree in economics from Dartmouth College in 1965 and an MBA fro Columbia Business School in 1967. He resides in New York City with his wife Judy and their two children.
Friedman, Billings, Ramsey & Co., Inc.
Co-Head of Healthcare Equity Investment Banking
Bob DeSutter is a managing director and co-head of the Health Care Team and has 14 years of investment banking experience. DeSutter started the health care advisory practice in 1996 and has transaction experience on numerous buy-side/sell-side, friendly/hostile, strategic/financial buyer and public/private deals. Since 1998, he has advised life sciences clients on sale transactions to Abbott Labs, Astra, Biomet, Boston Scientific, Cardinal Health, Thermo Fisher, Medtronic, Johnson & Johnson, Pfizer, St. Jude, Covidien, Smith & Nephew, GE Medical and Novartis, among others. DeSutter has completed financing transactions involving public and private equity, convertible debt, subordinated debt and senior secured debt. DeSutter is a graduate of the University of Minnesota and the University of Virginia's Darden Graduate School of Business.
CHARLES J. DITKOFF
and Co-Head of Global Healthcare Group
Corporate & Investment Banking
Banc of America Securities
Charles joined Bank of America in 1999 as a managing director responsible for BAS’s coverage of healthcare service providers and distributors. He was given responsibility for all of GCIB’s healthcare services coverage mid 2003. Charles is one of the most recognized bankers covering healthcare services on Wall Street. Under his direction, BAS has gained the leading market share in the sector in both M&A and financings. Prior to joining the firm, he worked for five years in the Corporate Finance Group at Morgan Stanley primarily focusing on Healthcare. Mr. Ditkoff also worked at Credit Suisse First Boston from 1992 to 1994 as Vice President. Prior to that, he was an Associate at Cravath, Swaine and Moore for five years as a corporate securities lawyer.
Charles graduated from Brown University Phi Beta Kappa and magna cum laude with a degree in Political Science and received a J.D. from Yale Law School.
CCMP Capital Advisors, LLC
Benjamin Edmands is a Managing Director in the New York office of CCMP Capital. Mr. Edmands focuses on making investments in the healthcare sector and has been responsible for CCMP's investments in CareMore Medical Enterprises, Hanger, DJ Orthopedics, MedQuest Associates and Warner Chilcott. Prior to joining CCMP in 1993, Mr. Edmands worked in Chemical Bank's Investment Banking Group and Structured Finance Group. He holds a B.A. from Colgate University and an M.B.A. from Columbia Business School. Mr. Edmands currently serves on the board of directors of CareMore Medical Enterprises, MedQuest Associates, National Surgical Care and Warner Chilcott.
As a premier private equity firm, CCMP Capital Advisors, LLC has invested over $10 billion in over 375 buyout and growth equity transactions since 1984. The foundation of CCMP Capital’s investment approach is to leverage the combined strengths of its deep industry expertise and proprietary global network of relationships by focusing on six targeted industries: Healthcare Infrastructure, Consumer, Retail and Services, Energy, Financial Services, Industrials and Media and Telecom. Prior to forming CCMP Capital, the firm’s principals led the buyout and growth equity investment business of J.P. Morgan Partners, LLC, a private equity division of JPMorgan Chase & Co. CCMP Capital follows the successful investment strategy its principals developed and implemented as members of JPMorgan Partners.
STEVEN ELEK, III
Partner, Healthcare Transaction Services Leader
Steve, a partner, leads the Healthcare Practice in the Transaction Services Group of PricewaterhouseCoopers LLP. He is responsible for delivering a wide range of merger, acquisition, divestiture and corporate finance related services. Steve has over twenty-five years of experience in a wide range of healthcare industry sectors that gives him a broad understanding of the interrelationships amongst the sectors. His sector experience includes health insurance/managed care, general acute-care hospitals, psychiatric hospitals, integrated delivery systems, long-term care, rehabilitation centers, home care, clinical laboratories, medical device manufacturers, and pharmaceutical companies.
Steve is an attorney, a Certified Public Accountant, a past President of the Association for Corporate Growth's Philadelphia Chapter and a past Chairman of its Board of Directors. He is a member of the Healthcare Financial Management Association, American Institute of Certified Public Accountants, Pennsylvania Institute of Certified Public Accountants, the Pennsylvania Bar Association and the Philadelphia Bar Association. Steve is a frequent speaker and author on various acquisition, divestiture and financing topics.
Partner, Head of U.S. Healthcare
Apax Partners LP Buddy Gumina is a Partner and Head of US Healthcare at Apax Partners where he focuses on investments in healthcare services, products, pharma and healthcare IT. Some recent deals have included Qualitest Pharmaceuticals, Spectrum Laboratory Network, Encompass Home Health, Voyager HospiceCare, Inc. and MagnaCare Holdings, Inc.
Prior to joining Apax Partners, Buddy was a Partner at Saunders Karp & Megrue, where he specialized in investments in healthcare and business services. Before joining Saunders Karp & Megrue, Buddy was an Associate at DLJ Merchant Banking Partners where he focused on healthcare services as well as the industrial and engineered chemical sectors. Prior to that, he was an Analyst in the High Yield Group of Kidder, Peabody & Co. where he specialized in public and private debt financings and recapitalizations.
Buddy received an MBA from the Harvard Graduate School of Business Administration and a BA in Political Science from Yale University.
Board Memberships: Qualitest Pharmaceuticals; Spectrum Laboratory Network; Voyager HospiceCare, Inc.; MagnaCare Holdings, Inc.; Applied Tech Products
KENNETH W. HITCHNER
Partner, Global Head of Healthcare Investment Banking
Ken is head of the healthcare banking group. He joined Goldman Sachs in 1992 as a member of the Corporate Finance Department. In 1995, Ken joined the healthcare group as a founding member. He became head of Goldman Sachs’ global medical device banking practice in 2001. He was named managing director in 2000 and partner in 2002. Prior to joining the firm, Ken was a lieutenant commander and naval aviator in the US Navy. He is a trustee and member of the Board of Meridian Health Systems, Monmouth University and The Rumson Country Day School. Ken earned a BA from University of Colorado and an MBA as a merit fellow at Columbia University Business School. Selected transactions include Pfizer/Warner-Lambert, Warner-Lambert/Agouron, Johnson & Johnson/ Alza, Johnson & Johnson/ Pfizer Consumer, GE/Amersham, GE/Instrumentarium, Medtronic/Minimed, Metronic/Kyphon, Lilly/ICOS.
MICHAEL J. KAPLAN
Managing Director, Corporate Ratings
Health Care Team Leader
Standard & Poor's
Michael J. Kaplan is a Managing Director in Standard & Poor’s Industrial Ratings Group and coordinates the activities of the global HealthCare team. Michael has been associated with Standard & Poor’s for some 30 years, and since 1983, has specialized in the analysis of companies providing health care services, supplies and equipment, and pharmaceuticals. As the Health Care team leader, he has broad and deep knowledge of health care issues, highlighted by award-winning roles at Standard and Poor’s in the development of health care rating criteria and in the publishing arena.
He has extensive discussions with leaders in the health care field as a part of the rating process, and shares his perspective on health care developments in a variety of public forums, including electronic and print media. Michael also has ongoing dialogue with Standard & Poor’s analysts in health-related rating sectors in the Public and Structured Finance departments, as well as in the Insurance Services area.
Michael holds an M.B.A. from New York University's Graduate School of Business and a B.S. from Brooklyn College of the City University of New York. He also is a member of the New York Society of Security Analysts.
Kenneth Klee leads editorial operations for Corporate Dealmaker, launched by The Deal, LLC in November 2003. Corporate Dealmaker, a bimonthly magazine complemented with a Web site and conferences, helps corporate dealmakers succeed in the deal economy.
Klee's previous editorial post was at Newsweek International, where he oversaw the magazine's business section as a senior editor. He wrote on international business topics for Newsweek's domestic and international editions and orchestrated various special sections on international economic and business trends. For much of the 1990's, Klee was the managing editor of Institutional Investor's international editions, responsible for coverage in Europe and Asia. He began his tenure at Institutional Investor in 1987 as a senior editor focused on commercial banking and Wall Street.
Klee started his journalism career at Forbes, working on the copy desk. Shortly thereafter, he moved to a technology publication, Datamation, as features editor and later to Venture Magazine as managing editor. Klee earned a bachelors of arts degree in English literature from the University of Wisconsin.
MICHAEL J. KLUGER
Altaris Capital Partners, LLC
Mr. Kluger is a founding partner of Altaris. Prior to the formation of Altaris, Mr. Kluger was a founding partner of Liberty Partners where he specialized in healthcare investments. Prior to Liberty Partners, Mr. Kluger held various positions in Merrill Lynch’s private equity and investment banking groups. Mr. Kluger received a B.A. in History from Trinity College and an M.B.A. from the University of Chicago, with a concentration in hospital administration.
Mr. Kluger is currently a board member of the following Altaris portfolio companies: Brim Healthcare, Classic Industries, Healthcare Waste Solutions, Intermed-Penlon, M2S, Paragon Medical and U.S. HealthWorks. In addition, Mr. Kluger is or has been a member of the board of directors of several publicly traded companies, including Allscripts Healthcare Solutions (NASDAQ), Foundation Health Corporation (NYSE), Monaco Coach Corporation (NYSE) and NFO Research (NYSE).
CECILE KOHRS LINDELL
The Deal LLC
Cecile Kohrs Lindell covers antitrust regulation and related issues for The Deal, LLC.
Prior to coming to The Deal in 2006, Lindell worked as a lawyer at the Federal Trade Commission, where she was responsible for sections of the joint FTC/Department of Justice report on competition and regulatory issues surrounding the health care industry, “Improving Health Care: A Dose of Competition.” She also spoke about the importance of communication and antitrust law at the Organisation for Economic Co-operation and Development in Paris in February 2006.
While attending law school, Lindell was a reporter for BridgeNews, where she also covered antitrust law; reporting and writing about mergers, criminal cartel enforcement and class actions. She also worked in the Washington office of Fried Frank Harris Shriver & Jacobson LLP.
After graduating from San Diego State University with a bachelor’s of arts degree in journalism, Lindell covered government and the courts at community newspapers in the Washington D.C. region. She received her juris doctorate degree from George Mason University’s School of Law.
Francisco Partners, L.P.
Mr. Perlman is a Partner with Francisco Partners, and focuses primarily on investments in the software and services sectors, with a specific emphasis on healthcare technology. Francisco Partners is a technology-focused private equity firm with $5 billion under management and offices in San Francisco and London. Mr. Perlman serves on the board of directors of AdvancedMD, Attachmate, Dairyland Healthcare Solutions, and RedPrairie. He is a former director of LYNX Medical Systems (acquired by Picis), SMART Modular (SMOD), and FX Solutions. Prior to joining Francisco Partners, Mr. Perlman was a venture capitalist with Battery Ventures, where he was involved in identifying, executing and managing private equity investments in software companies. Earlier in his career, Mr. Perlman was an executive in the credit card industry with Advanta and a management consultant with Oliver, Wyman & Company. Mr. Perlman has an MBA from Stanford Graduate School of Business and a BA in Applied Mathematics from Harvard University.
Mr. Sisitsky leads the investment activities of TPG V in the healthcare services and pharmaceutical / medical device sectors. He played lead roles in connection with TPG’s investments in IASIS Healthcare, Fenwal Inc., Surgical Care Affiliates and Biomet, and serves on the boards of each of these companies. Prior to joining TPG in 2003, Mr. Sisitsky worked at Forstmann Little & Company and Oak Hill Capital Partners. He received an M.B.A. from the Stanford Graduate School of Business where he was an Arjay Miller Scholar, and earned his undergraduate degree from Dartmouth College, where he graduated summa cum laude.
NATHANIEL M. ZILKHA
Kohlberg Kravis Roberts & Co.
Nat Zilkha is a Principal at KKR where he focuses on investments in healthcare. Prior to joining KKR, Mr. Zilkha was at Goldman Sachs, where he led the healthcare investing efforts for the Goldman Sachs Capital Partners funds. Over his career he has invested over $1.5 billion of equity in various sectors of healthcare including services, managed care, medical devices and pharmaceuticals. Mr. Zilkha graduated from Princeton University.
The Healthcare Dealmaking Symposium provides a unique opportunity to position yourself and/or your firm as thought leaders in the healthcare, medical device, biotechnology and drug discovery sectors in a face-to-face environment with the corporate and financial executives who will drive the deals in 2008.
To be considered for a speaking role, please send your information to:
Manager, Program Development
The Healthcare Dealmaking Symposium